Veterinary Active Pharmaceutical Ingredients (API) - Global and China Top Players Market Share and Ranking 2023
According to YH Research, the global market for Veterinary Active Pharmaceutical Ingredients (API) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Veterinary Active Pharmaceutical Ingredients (API) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Veterinary Active Pharmaceutical Ingredients (API) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, CDMO grew percent to account for percent of the total market sales, and CMO grew percent.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
This report studies and analyses global Veterinary Active Pharmaceutical Ingredients (API) status and future trends, helps the client to determine the Veterinary Active Pharmaceutical Ingredients (API) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Veterinary Active Pharmaceutical Ingredients (API), and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Veterinary Active Pharmaceutical Ingredients (API) market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Veterinary Active Pharmaceutical Ingredients (API) sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Veterinary Active Pharmaceutical Ingredients (API) sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Veterinary Active Pharmaceutical Ingredients (API) key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Veterinary Active Pharmaceutical Ingredients (API) key producing regions, capacity, production, and year over year growth
(6) Veterinary Active Pharmaceutical Ingredients (API) industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Market segment by Type, covers
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
Market segment by Application, can be divided into
CDMO
CMO
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Veterinary Active Pharmaceutical Ingredients (API) product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Veterinary Active Pharmaceutical Ingredients (API) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Veterinary Active Pharmaceutical Ingredients (API) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Veterinary Active Pharmaceutical Ingredients (API), percent & CAGR, 2018-2029
Chapter 5: Veterinary Active Pharmaceutical Ingredients (API) industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Veterinary Active Pharmaceutical Ingredients (API) Definition
1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast
1.2.1 By Consumption Value, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size，2018-2029
1.2.2 By Sales Quantity, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size，2018-2029
1.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP)，2018-2029
1.3 China Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast
1.3.1 By Consumption Value, China Veterinary Active Pharmaceutical Ingredients (API) Market Size，2018-2029
1.3.2 By Sales Quantity, China Veterinary Active Pharmaceutical Ingredients (API) Market Size，2018-2029
1.3.3 China Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP)， 2018-2029
1.4 Share of China Veterinary Active Pharmaceutical Ingredients (API) Market with Respect to the Global Market
1.4.1 By Consumption Value, China Veterinary Active Pharmaceutical Ingredients (API) Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Veterinary Active Pharmaceutical Ingredients (API) Market Share in Global, 2018-2029
1.4.3 Veterinary Active Pharmaceutical Ingredients (API) Market Size: China VS Global, 2018-2029
1.5 Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
1.5.1 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
1.5.2 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
1.5.3 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
1.5.4 Veterinary Active Pharmaceutical Ingredients (API) Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Veterinary Active Pharmaceutical Ingredients (API), Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Veterinary Active Pharmaceutical Ingredients (API), Global Market Share by Company, 2018-2023
2.3 Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Veterinary Active Pharmaceutical Ingredients (API) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Veterinary Active Pharmaceutical Ingredients (API) Concentration Ratio
2.6 Global Veterinary Active Pharmaceutical Ingredients (API) Mergers & Acquisitions, Expansion Plans
2.7 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Product Type
2.8 Head Office and Veterinary Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer
2.9 Veterinary Active Pharmaceutical Ingredients (API) Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Veterinary Active Pharmaceutical Ingredients (API), China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Veterinary Active Pharmaceutical Ingredients (API), China Market Share by Company, 2018-2023
3.3 China Veterinary Active Pharmaceutical Ingredients (API) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Capacity by Region
4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Veterinary Active Pharmaceutical Ingredients (API) Production by Region, 2018-2029
4.5 Global Veterinary Active Pharmaceutical Ingredients (API) Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Chain
5.2 Veterinary Active Pharmaceutical Ingredients (API) Upstream Analysis
5.2.1 Veterinary Active Pharmaceutical Ingredients (API) Core Raw Materials
5.2.2 Main Manufacturers of Veterinary Active Pharmaceutical Ingredients (API) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Veterinary Active Pharmaceutical Ingredients (API) Production Mode
5.6 Veterinary Active Pharmaceutical Ingredients (API) Procurement Model
5.7 Veterinary Active Pharmaceutical Ingredients (API) Industry Sales Model and Sales Channels
5.7.1 Veterinary Active Pharmaceutical Ingredients (API) Sales Model
5.7.2 Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
6 Sights by Type
6.1 Veterinary Active Pharmaceutical Ingredients (API) Classification
6.1.1 Chemical Based API
6.1.2 Biological API
6.1.3 Highly Potent APl(HPAPI)
6.2 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029
6.4 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029
6.5 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Veterinary Active Pharmaceutical Ingredients (API) Segment by Application
7.1.1 CDMO
7.1.2 CMO
7.2 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029
7.4 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029
7.5 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029
8.3 By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Veterinary Active Pharmaceutical Ingredients (API) & Forecasts, 2018-2029
8.4.2 By Country, North America Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.5 Europe
8.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.7 South America
8.7.1 South America Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029
9.3 By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.4.2 By Type, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.5.2 By Type, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.6.2 By Type, China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.7.2 By Type, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.8.2 By Type, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.10.2 By Type, India Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Alivira Animal Health Ltd
10.1.1 Alivira Animal Health Ltd Company Information, Head Office, Market Area, and Industry Position
10.1.2 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Alivira Animal Health Ltd Company Profile and Main Business
10.1.5 Alivira Animal Health Ltd Recent Developments
10.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
10.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information, Head Office, Market Area, and Industry Position
10.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Profile and Main Business
10.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
10.3 Procyon Life Sciences
10.3.1 Procyon Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.3.2 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Procyon Life Sciences Company Profile and Main Business
10.3.5 Procyon Life Sciences Recent Developments
10.4 SUANFARMAOfichem Group
10.4.1 SUANFARMAOfichem Group Company Information, Head Office, Market Area, and Industry Position
10.4.2 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 SUANFARMAOfichem Group Company Profile and Main Business
10.4.5 SUANFARMAOfichem Group Recent Developments
10.5 NGL Fine-Chem Ltd
10.5.1 NGL Fine-Chem Ltd Company Information, Head Office, Market Area, and Industry Position
10.5.2 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 NGL Fine-Chem Ltd Company Profile and Main Business
10.5.5 NGL Fine-Chem Ltd Recent Developments
10.6 Huvepharma
10.6.1 Huvepharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Huvepharma Company Profile and Main Business
10.6.5 Huvepharma Recent Developments
10.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
10.7.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information, Head Office, Market Area, and Industry Position
10.7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.7.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Profile and Main Business
10.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
10.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
10.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information, Head Office, Market Area, and Industry Position
10.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Profile and Main Business
10.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
10.9 Menadiona
10.9.1 Menadiona Company Information, Head Office, Market Area, and Industry Position
10.9.2 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Menadiona Company Profile and Main Business
10.9.5 Menadiona Recent Developments
10.10 lndukern Group
10.10.1 lndukern Group Company Information, Head Office, Market Area, and Industry Position
10.10.2 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 lndukern Group Company Profile and Main Business
10.10.5 lndukern Group Recent Developments
10.11 LasaSupergenerics Ltd.
10.11.1 LasaSupergenerics Ltd. Company Information, Head Office, Market Area, and Industry Position
10.11.2 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
10.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 LasaSupergenerics Ltd. Company Profile and Main Business
10.11.5 LasaSupergenerics Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
Table 3. Veterinary Active Pharmaceutical Ingredients (API) Market Trends
Table 4. Veterinary Active Pharmaceutical Ingredients (API) Industry Policy
Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Veterinary Active Pharmaceutical Ingredients (API) Mergers & Acquisitions, Expansion Plans
Table 12. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Product Type
Table 13. Head Office and Veterinary Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer
Table 14. Veterinary Active Pharmaceutical Ingredients (API) Capacity of Major Manufacturers and Future Plan
Table 15. China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Veterinary Active Pharmaceutical Ingredients (API) Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Veterinary Active Pharmaceutical Ingredients (API) Production by Region, 2018-2023, (K Units)
Table 20. Global Veterinary Active Pharmaceutical Ingredients (API) Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Veterinary Active Pharmaceutical Ingredients (API) Upstream (Raw Materials)
Table 22. Global Veterinary Active Pharmaceutical Ingredients (API) Typical Customers
Table 23. Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
Table 24. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2018-2029
Table 34. Alivira Animal Health Ltd Company Information, Head Office, Market Area, and Industry Position
Table 35. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 36. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Alivira Animal Health Ltd Company Profile and Main Business
Table 38. Alivira Animal Health Ltd Recent Developments
Table 39. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information, Head Office, Market Area, and Industry Position
Table 40. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 41. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Profile and Main Business
Table 43. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
Table 44. Procyon Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 45. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 46. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Procyon Life Sciences Company Profile and Main Business
Table 48. Procyon Life Sciences Recent Developments
Table 49. SUANFARMAOfichem Group Company Information, Head Office, Market Area, and Industry Position
Table 50. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 51. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. SUANFARMAOfichem Group Company Profile and Main Business
Table 53. SUANFARMAOfichem Group Recent Developments
Table 54. NGL Fine-Chem Ltd Company Information, Head Office, Market Area, and Industry Position
Table 55. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 56. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. NGL Fine-Chem Ltd Company Profile and Main Business
Table 58. NGL Fine-Chem Ltd Recent Developments
Table 59. Huvepharma Company Information, Head Office, Market Area, and Industry Position
Table 60. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 61. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Huvepharma Company Profile and Main Business
Table 63. Huvepharma Recent Developments
Table 64. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information, Head Office, Market Area, and Industry Position
Table 65. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 66. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Profile and Main Business
Table 68. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
Table 69. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information, Head Office, Market Area, and Industry Position
Table 70. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 71. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Profile and Main Business
Table 73. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
Table 74. Menadiona Company Information, Head Office, Market Area, and Industry Position
Table 75. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 76. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Menadiona Company Profile and Main Business
Table 78. Menadiona Recent Developments
Table 79. lndukern Group Company Information, Head Office, Market Area, and Industry Position
Table 80. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 81. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. lndukern Group Company Profile and Main Business
Table 83. lndukern Group Recent Developments
Table 84. LasaSupergenerics Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 85. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications, and Application
Table 86. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. LasaSupergenerics Ltd. Company Profile and Main Business
Table 88. LasaSupergenerics Ltd. Recent Developments
List of Figures
Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Picture
Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units) & (2018-2029)
Figure 7. China Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Veterinary Active Pharmaceutical Ingredients (API) Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Veterinary Active Pharmaceutical Ingredients (API) Market Share of Global, 2018-2029
Figure 10. Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Veterinary Active Pharmaceutical Ingredients (API) Key Participants, Market Share, 2022
Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Production Market Share & Forecast by Region, 2018-2029
Figure 15. Veterinary Active Pharmaceutical Ingredients (API) Industry Chain
Figure 16. Veterinary Active Pharmaceutical Ingredients (API) Procurement Model
Figure 17. Veterinary Active Pharmaceutical Ingredients (API) Sales Model
Figure 18. Veterinary Active Pharmaceutical Ingredients (API) Sales Channels, Direct Sales, and Distribution
Figure 19. Chemical Based API
Figure 20. Biological API
Figure 21. Highly Potent APl(HPAPI)
Figure 22. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. CDMO
Figure 28. CMO
Figure 29. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2018-2029
Figure 36. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2022
Figure 38. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2022
Figure 40. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2022
Figure 42. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets